An antibody-free, ultrafiltration-based assay for the detection of growth hormone-releasing hormones in urine at low pg/mL concentrations using nanoLC-HRMS/MS.
暂无分享,去创建一个
[1] V. Abbate,et al. Advances in the Detection of Growth Hormone Releasing Hormone Synthetic Analogs. , 2021, Drug testing and analysis.
[2] K. Deventer,et al. Combining direct urinary injection with automated filtration and nanoflow LC-MS for the confirmatory analysis of doping-relevant small peptide hormones. , 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[3] K. Deventer,et al. Doping control analysis of small peptides: A decade of progress. , 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[4] R. Ventura,et al. Comparison of magnetic bead surface functionalities for the immunopurification of growth hormone-releasing hormones prior to liquid chromatography-high resolution mass spectrometry. , 2020, Journal of chromatography. A.
[5] K. Deventer,et al. A high-throughput assay for the quantification of intact Insulin-Like Growth Factor I in human serum using online SPE-LC-HRMS. , 2020, Clinica chimica acta; international journal of clinical chemistry.
[6] K. Deventer,et al. Urinary detection of rapid-acting insulin analogues in healthy humans. , 2020, Drug testing and analysis.
[7] F. Lanças,et al. Miniaturized liquid chromatography focusing on analytical columns and mass spectrometry: A review. , 2020, Analytica chimica acta.
[8] M. Thevis,et al. Identification of metabolites of peptide-derived drugs using an isotope-labeled reporter ion screening strategy , 2019, Clinical chemistry and laboratory medicine.
[9] E. Deconinck,et al. Falsification of biotechnology drugs: current dangers and/or future disasters? , 2018, Journal of pharmaceutical and biomedical analysis.
[10] K. Deventer,et al. Adsorption effects of the doping relevant peptides Insulin Lispro, Synachten, TB-500 and GHRP 5. , 2017, Analytical biochemistry.
[11] M. Thevis,et al. Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS , 2016, Analytical and Bioanalytical Chemistry.
[12] J. Namieśnik,et al. Miniaturized solid-phase extraction techniques , 2015 .
[13] Steven Ray Wilson,et al. Nano-LC in proteomics: recent advances and approaches. , 2015, Bioanalysis.
[14] M. Thevis,et al. Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MS. , 2015, Drug testing and analysis.
[15] K. Deventer,et al. Identification of the growth hormone-releasing hormone analogue [Pro1, Val14]-hGHRH with an incomplete C-term amidation in a confiscated product. , 2014, Drug testing and analysis.
[16] Koen Deventer,et al. Dilute-and-shoot-liquid chromatography-mass spectrometry for urine analysis in doping control and analytical toxicology , 2014 .
[17] Wilhelm Schänzer,et al. Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls. , 2012, Methods.
[18] E. Lundanes,et al. Automatic filtration and filter flush for robust online solid-phase extraction liquid chromatography. , 2011, Journal of separation science.
[19] M. Thevis,et al. Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry , 2011, Analytical and bioanalytical chemistry.
[20] P. Hemmersbach,et al. Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation. , 2010, Drug testing and analysis.
[21] D. Potvin,et al. Effects of Tesamorelin, a Growth Hormone–Releasing Factor, in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial With a Safety Extension , 2010, Journal of acquired immune deficiency syndromes.
[22] M. Thevis,et al. Proteases in Doping Control Analysis , 2007, International journal of sports medicine.
[23] Wilhelm Schänzer,et al. Recommended criteria for the mass spectrometric identification of target peptides and proteins (<8 kDa) in sports drug testing. , 2007, Rapid communications in mass spectrometry : RCM.
[24] D. Bridon,et al. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. , 2005, Endocrinology.
[25] M. Chance,et al. Secondary reactions and strategies to improve quantitative protein footprinting. , 2005, Analytical chemistry.
[26] P. Caliceti,et al. PEGylation of growth hormone-releasing hormone (GRF) analogues. , 2003, Advanced drug delivery reviews.
[27] M. Karas,et al. Effect of different solution flow rates on analyte ion signals in nano-ESI MS, or: when does ESI turn into nano-ESI? , 2003, Journal of the American Society for Mass Spectrometry.
[28] J. Veldhuis,et al. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. , 1998, Endocrine reviews.
[29] C. Cramers,et al. Microcolumn liquid chromatography: Instrumentation, detection and applications , 1997 .
[30] J. Jansson,et al. Growth hormone-releasing hormone. , 1986, Endocrine reviews.
[31] H. Kaji,et al. L-dopa stimulates release of hypothalamic growth hormone-releasing hormone in humans. , 1986, The Journal of clinical endocrinology and metabolism.